MedPath

Effectiveness of Ezetimibe or Pitavastatin calcium calcium in NASH/NAFLD patients with high cholesterol levels: a randomized controlled study

Phase 2
Completed
Conditions
The NASH/NAFLD patients with high cholesterol level
Registration Number
JPRN-UMIN000003055
Lead Sponsor
Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

1)The patients with the use of drugs for dyslipidemia within 4 weeks 2)The patients with chronic kidney disease (serum Cre>2.0) or severe liver dysfunction 3)The patients who are pregnant or giving the breast to a baby or want to be pregnat within the period of trial. 4)The patients with cyclosporin 5)The patients with liver dysfunction by drug, alchol, virus, or autoimmnue factors.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The level of alanine aminotransferase
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath